These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

488 related items for PubMed ID: 21715012

  • 1. Selective ophthalmic arterial injection therapy for intraocular retinoblastoma: the long-term prognosis.
    Suzuki S, Yamane T, Mohri M, Kaneko A.
    Ophthalmology; 2011 Oct; 118(10):2081-7. PubMed ID: 21715012
    [Abstract] [Full Text] [Related]

  • 2. Occurrence of sectoral choroidal occlusive vasculopathy and retinal arteriolar embolization after superselective ophthalmic artery chemotherapy for advanced intraocular retinoblastoma.
    Munier FL, Beck-Popovic M, Balmer A, Gaillard MC, Bovey E, Binaghi S.
    Retina; 2011 Mar; 31(3):566-73. PubMed ID: 21273941
    [Abstract] [Full Text] [Related]

  • 3. A phase I/II study of direct intraarterial (ophthalmic artery) chemotherapy with melphalan for intraocular retinoblastoma initial results.
    Abramson DH, Dunkel IJ, Brodie SE, Kim JW, Gobin YP.
    Ophthalmology; 2008 Aug; 115(8):1398-404, 1404.e1. PubMed ID: 18342944
    [Abstract] [Full Text] [Related]

  • 4. Selective ophthalmic arterial injection of melphalan for intraocular retinoblastoma: a 4-year review.
    Ong SJ, Chao AN, Wong HF, Liou KL, Kao LY.
    Jpn J Ophthalmol; 2015 Mar; 59(2):109-17. PubMed ID: 25465196
    [Abstract] [Full Text] [Related]

  • 5. Efficacy and complications of super-selective intra-ophthalmic artery melphalan for the treatment of refractory retinoblastoma.
    Muen WJ, Kingston JE, Robertson F, Brew S, Sagoo MS, Reddy MA.
    Ophthalmology; 2012 Mar; 119(3):611-6. PubMed ID: 22197434
    [Abstract] [Full Text] [Related]

  • 6. Superselective ophthalmic artery chemotherapy as primary treatment for retinoblastoma (chemosurgery).
    Abramson DH, Dunkel IJ, Brodie SE, Marr B, Gobin YP.
    Ophthalmology; 2010 Aug; 117(8):1623-9. PubMed ID: 20381868
    [Abstract] [Full Text] [Related]

  • 7. The technique of ophthalmic arterial infusion therapy for patients with intraocular retinoblastoma.
    Yamane T, Kaneko A, Mohri M.
    Int J Clin Oncol; 2004 Apr; 9(2):69-73. PubMed ID: 15108036
    [Abstract] [Full Text] [Related]

  • 8. Minimal exposure (one or two cycles) of intra-arterial chemotherapy in the management of retinoblastoma.
    Shields CL, Kaliki S, Shah SU, Bianciotto CG, Liu D, Jabbour P, Griffin GC, Shields JA.
    Ophthalmology; 2012 Jan; 119(1):188-92. PubMed ID: 21975042
    [Abstract] [Full Text] [Related]

  • 9. Intra-arterial chemotherapy is more effective than sequential periocular and intravenous chemotherapy as salvage treatment for relapsed retinoblastoma.
    Schaiquevich P, Ceciliano A, Millan N, Taich P, Villasante F, Fandino AC, Dominguez J, Chantada GL.
    Pediatr Blood Cancer; 2013 May; 60(5):766-70. PubMed ID: 23024125
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Autonomic cardio-respiratory reflex reactions and superselective ophthalmic arterial chemotherapy for retinoblastoma.
    Phillips TJ, McGuirk SP, Chahal HK, Kingston J, Robertson F, Brew S, Roebuck D, Hungerford JL, Herod J.
    Paediatr Anaesth; 2013 Oct; 23(10):940-5. PubMed ID: 23668238
    [Abstract] [Full Text] [Related]

  • 12. Visual outcomes following intraophthalmic artery melphalan for patients with refractory retinoblastoma and age appropriate vision.
    Tsimpida M, Thompson DA, Liasis A, Smith V, Kingston JE, Sagoo MS, Reddy MA.
    Br J Ophthalmol; 2013 Nov; 97(11):1464-70. PubMed ID: 24037611
    [Abstract] [Full Text] [Related]

  • 13. Intra-arterial chemotherapy for retinoblastoma in 70 eyes: outcomes based on the international classification of retinoblastoma.
    Shields CL, Manjandavida FP, Lally SE, Pieretti G, Arepalli SA, Caywood EH, Jabbour P, Shields JA.
    Ophthalmology; 2014 Jul; 121(7):1453-60. PubMed ID: 24656794
    [Abstract] [Full Text] [Related]

  • 14. Intra-arterial chemotherapy for retinoblastoma: report No. 1, control of retinal tumors, subretinal seeds, and vitreous seeds.
    Shields CL, Bianciotto CG, Jabbour P, Ramasubramanian A, Lally SE, Griffin GC, Rosenwasser R, Shields JA.
    Arch Ophthalmol; 2011 Nov; 129(11):1399-406. PubMed ID: 21670328
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Selective ophthalmic artery infusion of chemotherapy for advanced intraocular retinoblastoma: initial experience with 17 tumors.
    Peterson EC, Elhammady MS, Quintero-Wolfe S, Murray TG, Aziz-Sultan MA.
    J Neurosurg; 2011 Jun; 114(6):1603-8. PubMed ID: 21294621
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Selective ophthalmic arterial injection using a balloon catheter for retinoblastoma: a seven-year clinical evaluation.
    Oguro S, Chen YN, Yamane T, Mohri M, Suzuki S.
    Jpn J Ophthalmol; 2024 Jul; 68(4):346-354. PubMed ID: 38833074
    [Abstract] [Full Text] [Related]

  • 19. Fluorescein angiographic findings after intra-arterial chemotherapy for retinoblastoma.
    Bianciotto C, Shields CL, Iturralde JC, Sarici A, Jabbour P, Shields JA.
    Ophthalmology; 2012 Apr; 119(4):843-9. PubMed ID: 22137042
    [Abstract] [Full Text] [Related]

  • 20. Intravitreal injection of melphalan for intraocular retinoblastoma.
    Suzuki S, Aihara Y, Fujiwara M, Sano S, Kaneko A.
    Jpn J Ophthalmol; 2015 May; 59(3):164-72. PubMed ID: 25808017
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.